IOMEPROL: Active name: IOMEPROL Brand name: IOMERVU Innovator name BRACCO DIAGNOSTICS INC Approval Date: NOV 27, 2024 Therapeutic activity: Tri-iodinated X-Ray contrasting agent. Iomeprol has been investigated for the diagnostic of Coronary Artery Disease. Route of administration Intra arterial/intravenous, Injection Structure Chemical name N,N’-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)- methylamino]-2,4,6-tri-iodo-1,3-benzenedicarboxamide. CAS 78649-41-9 Dosage Available in four iodine concentration. 510 […]
API Flash News
Tag: Diagnostic agents
Back To Top